Scott Edmondson

Scott Edmondson is Vice President of Drug Discovery at Nimbus Therapeutics and a leader in oncology and targeted protein degradation. Across senior roles at Nimbus Therapeutics, AstraZeneca, and Merck, he has advanced more than a dozen clinical candidates and contributed to two marketed medicines. He has also helped pioneer emerging modalities including PROTACs and is the author of over 65 publications and book chapters, alongside more than 65 patents and patent applications.